AMY HEUSINGER: Open Payments
NPI 1801194584 · DENVER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 23 payments from 11 companies in 2025. Trend: 2023 $1,970 · 2024 $2,290 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Fresenius Kabi USA, LLC | 6 | $116 |
| Janssen Biotech, Inc. | 3 | $78 |
| Amgen Inc. | 3 | $49 |
| ABBVIE INC. | 2 | $45 |
| ANI Pharmaceuticals, Inc. | 2 | $37 |
| Indivior Inc. | 1 | $33 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Radius Health, Inc. | 1 | $30 |
| UCB, Inc. | 1 | $20 |
| TerSera Therapeutics LLC | 1 | $19 |
Products named: TREMFYA, SKYRIZI, PURIFIED CORTROPHIN GEL, TAVNEOS, SUBLOCADE, XTAMPZA, Tymlos, Bimzelx.
Industry payments across NC — which companies pay providers there.
